Allogeneic
Cells or tissue from another person; scalable, but potentially recognized as foreign.
Reference
Definitions of terms used throughout the course.
Cells or tissue from another person; scalable, but potentially recognized as foreign.
An immune response against genetically different cells from another person.
A molecular feature that immune receptors can recognize.
An antibody against a self-associated target; in T1D, a marker of early autoimmune disease.
Immune attack against the body’s own cells or molecules.
Cells derived from and returned to the same person.
An islet endocrine cell that senses glucose and secretes insulin.
A peptide released with endogenous insulin and used to measure a patient’s or graft’s secretion.
The process by which a cell acquires a specialized identity and function.
Enclosing therapeutic cells in a semipermeable material to permit exchange while limiting immune access.
Establishment and survival of transplanted cells in the recipient.
Outside the body; ex vivo editing modifies cultured cells before transplantation.
Clinically meaningful endogenous insulin production, even if another chronic treatment remains.
Molecules that present protein fragments to T cells and strongly shape transplant matching.
Engineered to reduce immune recognition—not literally invisible to every immune pathway.
Treatment that broadly reduces immune activity to prevent rejection or control disease.
Maintaining glycemic control without external insulin during a defined observation period.
A vascularized endocrine micro-organ containing beta, alpha, delta, and other cell types.
Induced pluripotent stem cell: a mature cell reprogrammed to a pluripotent state.
An innate immune cell that can attack stressed cells, including those with unusually low HLA class I.
Able to self-renew and differentiate into nearly all adult cell types.
A test intended to predict whether a biological product performs its therapeutic function.
A T-cell subset that restrains immune responses and supports tolerance.
An immune state in which a target is not attacked while other immune responses remain available.